DSIP 15mg — Vial Spec, Reconstitution Math & COA

DSIP 15mg Specification Overview and Availability Notice

A 15mg vial of Delta Sleep-Inducing Peptide (DSIP) contains precisely 15 milligrams of purified, lyophilized nonapeptide powder formulated specifically for high-throughput, longitudinal, or multi-specimen laboratory research. This larger fill format is primarily ordered by academic institutions, contract research organizations (CROs), and analytical laboratories requiring substantial stock volumes to maintain concentration consistency across expansive experimental cohorts without introducing lot-to-lot variance.

Please note that PX1 Research maintains the standardized DSIP 5mg vial as its default off-the-shelf inventory unit. For high-volume research protocols requiring 15mg unit configurations or custom bulk batching, investigators can secure specialized production fills through our wholesale institutional channel. Both standard catalog items and custom institutional allocations undergo identical analytical verification, ensuring uncompromised purity regardless of packaging size.

Chemical Structure, Receptor Targets, and Preclinical Literature

Delta Sleep-Inducing Peptide is an endogenous nonapeptide with the primary amino acid sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (MW: 848.81 g/mol). Discovered originally in cerebral venous blood during induced slow-wave sleep, the peptide exhibits complex interactions with the central nervous system, neuroendocrine axes, and cellular stress response pathways.

Preclinical studies suggest that DSIP readily crosses the blood-brain barrier via passive diffusion and saturable transport mechanisms. In vitro and rodent models demonstrate that the peptide modulates electroencephalographic (EEG) activity, specifically elevating delta-wave power spectra indicative of deep restorative sleep states without depressing overall neurological function. Furthermore, research indicates that DSIP exerts regulatory effects on the hypothalamic-pituitary-adrenal (HPA) axis, modulating basal corticosterone release and dampening plasma ACTH spikes under laboratory-induced stressors. Investigators exploring broader neurological regulators can review our full spectrum of compounds in the all-peptides catalog.

Unlike conventional sedative compounds, DSIP does not act as a direct agonist at classical GABA-A receptor sites. Instead, in vitro binding assays suggest indirect modulation of NMDA receptors, central monoamine turnover, and endogenous opioid pathways. These multifaceted mechanism profiles make DSIP a critical target for investigations centered on sleep architecture, autonomic balance, and neuroprotective recovery during sustained physiological stress.

Reconstitution Mathematics for 15mg Vials

Accurate reconstitution of a 15mg DSIP vial is essential for establishing precise volumetric concentrations in laboratory assays. Because a 15mg mass yields higher stock concentrations than standard 2mg or 5mg vials, researchers must carefully select diluent volume (typically Bacteriostatic Water or Sterile 0.9% Sodium Chloride) based on target assay sensitivity and micro-pipetting thresholds.

To calculate working concentrations ($C$), divide total mass ($m = 15\text{ mg}$) by the added diluent volume ($V$):

• 1.0 mL Diluent Addition: Yields a stock concentration of 15.0 mg/mL (15,000 µg/mL or 15 µg/µL). This high concentration is optimal for low-volume micro-injections or concentrated in vitro cell culture dosing where diluent volume must be minimized.

• 2.0 mL Diluent Addition: Yields a stock concentration of 7.5 mg/mL (7,500 µg/mL or 7.5 µg/µL). This concentration offers a practical balance between stock density and volumetric measuring precision for standard benchtop procedures.

• 3.0 mL Diluent Addition: Yields a stock concentration of 5.0 mg/mL (5,000 µg/mL or 5.0 µg/µL). This concentration simplifies aliquot calculations when target doses fall within standard milligram or microgram scales.

For custom volume calculations or complex molarity conversions, researchers are encouraged to utilize our interactive reconstitution-calculator to eliminate manual rounding errors prior to bench work.

Aliquot Planning and Liquid Handling Controls

When handling a 15mg high-yield vial, proper aliquot planning is critical to prevent degradation caused by repeated freeze-thaw cycles. Reconstituted peptides in aqueous solution suffer peptide bond hydrolysis and aggregation if subjected to multiple temperature oscillations.

Upon full reconstitution, the master solution should be immediately divided into single-use micro-centrifuge tubes (e.g., polypropylene, low-binding 0.5 mL or 1.5 mL tubes) under sterile laminar flow conditions. Each aliquot volume should correspond strictly to the daily requirements of the experimental protocol.

Working aliquots intended for immediate use within 24–48 hours may be held at 2°C to 8°C. Long-term aliquots must be flash-frozen and preserved at -20°C or -80°C. Avoid auto-defrost (frost-free) freezers, as their periodic warming cycles cause severe thermal stress and loss of peptide potency over time.

Lyophilized and Solution Handling & Storage Protocols

Preserving peptide stability requires adherence to strict physical and thermal storage parameters throughout every phase of handling. Prior to reconstitution, lyophilized DSIP 15mg vials must be stored in a dry, dark environment protected from direct light exposure.

Unopened lyophilized vials remain stable at room temperature (15°C to 25°C) for short transit periods, but long-term laboratory storage should be maintained at -20°C for up to 24 months. If stored at 2°C to 8°C, unopened lyophilized powder maintains structural integrity for approximately 12 months.

During reconstitution, ensure the diluent is gently streamed down the glass wall of the vial rather than sprayed directly onto the lyophilized cake. Allow the cake to hydrate naturally for 2 to 3 minutes, then gently swirl the vial until complete dissolution is achieved. Never shake, vortex, or subject the peptide solution to high-shear force, as mechanical agitation can denature the secondary structure and cause irreversible precipitation.

Lot-Matched COA, Purity Verification, and Quality Standards

Every production lot of DSIP supplied by PX1 Research undergoes rigorous testing in ISO 17025 accredited, independent third-party laboratories. Every 15mg unit fill—whether standard or custom custom-synthesized—is backed by an accessible, lot-matched Certificate of Analysis (COA).

Our comprehensive quality control protocol includes High-Performance Liquid Chromatography (HPLC) to confirm peptide purity exceeds 99.0%, ensuring the absence of truncated sequences or synthesis byproducts. Mass Spectrometry (MS) analysis verifies exact molecular weight ($848.81\text{ g/mol}$), confirming sequence fidelity.

Furthermore, all lots undergo quantitative Chromogenic LAL testing to verify endotoxin levels remain below strictly controlled thresholds (< 0.05 EU/mg), alongside bioburden screening. All peptides are synthesized in state-of-the-art, GMP-compliant facilities located within the United States, with orders fulfilled via same-day shipping (Monday–Friday) from our CA and AZ logistics hubs.

Selecting Fill Sizes: 5mg Catalog Stock vs. 15mg Custom Fills

Selecting between different unit fill masses depends entirely on experimental design, subject pool size, and consumption timelines. While a 15mg vial offers workflow efficiency for large-scale operations, smaller sizes present distinct logistical advantages for lower-volume assays.

For small cohort rodent studies, pilot in vitro screens, or intermittent dosing schedules, the standard catalog DSIP 5mg vial is typically ideal. A 5mg format minimizes the risk of solution degradation over extended holding periods, ensuring that freshly reconstituted peptide is utilized within optimal stability windows.

Conversely, high-density academic screening projects, automated liquid-handling systems, and continuous infusion models benefit from the 15mg configuration. Utilizing 15mg vials reduces packaging waste, minimizes inter-vial variance, and streamlines volumetric prep for large-scale study blocks.

Comparative Analysis: DSIP vs. Epitalon, Semax, and Selank in CNS Research

When evaluating neuroendocrine and sleep-architecture modulators, researchers frequently contrast DSIP with other prominent central nervous system research peptides. A comparative evaluation clarifies distinct receptor dynamics and experimental applications across these modalities.

• Delta Sleep-Inducing Peptide: Primarily investigated for delta-wave sleep induction, basal LH/ACTH regulation, and slow-wave sleep synchronization in preclinical models.

• Epitalon: Evaluated predominantly for telomerase activation, circadian rhythm stabilization via pineal gland regulation, and lifespan extension mechanisms in aging rodent models.

• Semax: A synthetic heptapeptide derived from ACTH(4-10), widely researched for BDNF elevation, neuroprotection against hypoxic stress, and cognitive parameter modulation.

• Selank: An synthetic analog of the endogenous tetrapeptide tuftsin, studied for anxiolytic modulation, GABAergic activity fine-tuning, and immune-neuroendocrine cross-talk.

Investigators interested in broader neurochemical literature and comparative study protocols can access technical articles across our primary research library hub.